Offering a wide variety of support to clients in the life sciences and health care sectors, Economic Laws Practice regularly advises on matters related to dispute resolution, competition and anti-trust, and corporate law. The team has expertise in advising clients on the new Uniform Code on Pharmaceutical Marketing Practices, as well as experience in front of the High Courts of India. Suhail Nathani is noted for his work in trade and competition laws, and Vinay Butani and Abhay Chattopadhyay are further key contacts.
Legal 500 Editorial commentary
Key clients
- Piramal Pharma Limited
- Johnson & Johnson Private Limited
- Mylan Laboratories Limited
- Siemens Limited; Siemens Healthcare Private Limited
- Advanced MedTech Solutions Pvt. Ltd.
- Somerset Indus Healthcare Fund II
- Somerset Indus Healthcare India Fund
- Stryker India Private Limited
- Alkem Medtech Private Limited
- Alkem Medtech Private Limited
- Datar Cancer Genetics Private Limited
- Zoetis Pharmaceutical Research Private Limited
- Bayer
- Max Healthcare Private Limited
Work highlights
Assisted a client with an anti-dumping investigation before the Directorate General of Trade Remedies seeking the imposition of anti-dumping duties on imports of "Vitamin A Palmitate" originating in or exported from China PR, the European Union, and Switzerland.
Assisted Johnson & Johnson with addressing complex issues arising under Rule 6 of the CENVAT Credit Rules, 2004, involving the apportionment of input credit used for manufacturing both taxable and exempt goods.
Assisted Alkem Medtech Private Limited with its 100% acquisition of Bombay Ortho Industries Private Limited by providing end-to-end legal support, including legal due diligence, drafting and negotiating transaction documents, and advising on pre-closing and closing actions to ensure a seamless and timely completion of the deal.
Practice head
Suhail Nathani
Other key lawyers
Vinay Butani; Abhay Chattopadhyay